Interleukin 6 Inhibition With Vamikibart for Uveitic Macular Edema: The Phase 1 DOVETAIL Nonrandomized Clinical Trial.
Saved in:
| Title: | Interleukin 6 Inhibition With Vamikibart for Uveitic Macular Edema: The Phase 1 DOVETAIL Nonrandomized Clinical Trial. |
|---|---|
| Authors: | Sharma S; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio., Lin P; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio., Hu A; Cumberland Valley Retina PC, Hagerstown, Maryland., Suhler EB; Casey Eye Institute and VA Portland Health Care System, Portland, Oregon., Pauly-Evers M; Roche Pharma Research and Early Development, Basel, Switzerland., Holmes W; Roche Products Ltd, Welwyn Garden City, United Kingdom., Barekati Z; Roche Pharma Research and Early Development, Basel, Switzerland., Willen D; Roche Pharma Research and Early Development, Basel, Switzerland., Macgregor L; F. Hoffmann-La Roche AG, Basel, Switzerland., Steeples L; Roche Products Ltd, Welwyn Garden City, United Kingdom., Haskova Z; Genentech, Inc, South San Francisco, California., Feenstra D; Roche Pharma Research and Early Development, Basel, Switzerland., Silverman D; Roche Products Ltd, Welwyn Garden City, United Kingdom., Passemard B; Roche Pharma Research and Early Development, Basel, Switzerland., Fauser S; Roche Pharma Research and Early Development, Basel, Switzerland., Mesquida M; Roche Pharma Research and Early Development, Basel, Switzerland.; F. Hoffmann-La Roche AG, Basel, Switzerland. |
| Source: | JAMA ophthalmology [JAMA Ophthalmol] 2026 May 01; Vol. 144 (5), pp. 442-451. |
| Publication Type: | Journal Article; Multicenter Study; Clinical Trial, Phase I |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print Cited Medium: Internet ISSN: 2168-6173 (Electronic) Linking ISSN: 21686165 NLM ISO Abbreviation: JAMA Ophthalmol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41954903 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Interleukin 6 Inhibition With Vamikibart for Uveitic Macular Edema: The Phase 1 DOVETAIL Nonrandomized Clinical Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sharma+S%22">Sharma S</searchLink>; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Lin+P%22">Lin P</searchLink>; Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Hu+A%22">Hu A</searchLink>; Cumberland Valley Retina PC, Hagerstown, Maryland.<br /><searchLink fieldCode="AU" term="%22Suhler+EB%22">Suhler EB</searchLink>; Casey Eye Institute and VA Portland Health Care System, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Pauly-Evers+M%22">Pauly-Evers M</searchLink>; Roche Pharma Research and Early Development, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Holmes+W%22">Holmes W</searchLink>; Roche Products Ltd, Welwyn Garden City, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Barekati+Z%22">Barekati Z</searchLink>; Roche Pharma Research and Early Development, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Willen+D%22">Willen D</searchLink>; Roche Pharma Research and Early Development, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Macgregor+L%22">Macgregor L</searchLink>; F. Hoffmann-La Roche AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Steeples+L%22">Steeples L</searchLink>; Roche Products Ltd, Welwyn Garden City, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Haskova+Z%22">Haskova Z</searchLink>; Genentech, Inc, South San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Feenstra+D%22">Feenstra D</searchLink>; Roche Pharma Research and Early Development, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Silverman+D%22">Silverman D</searchLink>; Roche Products Ltd, Welwyn Garden City, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Passemard+B%22">Passemard B</searchLink>; Roche Pharma Research and Early Development, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Fauser+S%22">Fauser S</searchLink>; Roche Pharma Research and Early Development, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mesquida+M%22">Mesquida M</searchLink>; Roche Pharma Research and Early Development, Basel, Switzerland.; F. Hoffmann-La Roche AG, Basel, Switzerland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101589539%22">JAMA ophthalmology</searchLink> [JAMA Ophthalmol] 2026 May 01; Vol. 144 (5), pp. 442-451. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Clinical Trial, Phase I – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101589539 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2168-6173 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221686165%22">21686165 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Ophthalmol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41954903 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1001/jamaophthalmol.2026.0610 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 442 Titles: – TitleFull: Interleukin 6 Inhibition With Vamikibart for Uveitic Macular Edema: The Phase 1 DOVETAIL Nonrandomized Clinical Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sharma S – PersonEntity: Name: NameFull: Lin P – PersonEntity: Name: NameFull: Hu A – PersonEntity: Name: NameFull: Suhler EB – PersonEntity: Name: NameFull: Pauly-Evers M – PersonEntity: Name: NameFull: Holmes W – PersonEntity: Name: NameFull: Barekati Z – PersonEntity: Name: NameFull: Willen D – PersonEntity: Name: NameFull: Macgregor L – PersonEntity: Name: NameFull: Steeples L – PersonEntity: Name: NameFull: Haskova Z – PersonEntity: Name: NameFull: Feenstra D – PersonEntity: Name: NameFull: Silverman D – PersonEntity: Name: NameFull: Passemard B – PersonEntity: Name: NameFull: Fauser S – PersonEntity: Name: NameFull: Mesquida M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2168-6173 Numbering: – Type: volume Value: 144 – Type: issue Value: 5 Titles: – TitleFull: JAMA ophthalmology Type: main |
| ResultId | 1 |